POST Online Media Lite Edition


Agilis Biotherapeutics appoints CEO

Staff writer |
New York, USA - January 2, 2014, New York, USA - Agilis Biotherapeutics, a synthetic biology-based company, announced the appointment of George Zorich as the company's chief executive.


John Weisel joins ZRG
Greene County Bancorp appoints Paul Slutzky as chairman
Indivior promotes Ryan Preblick to permanent CFO
Thermo Fisher Scientific appoints R. Alexandra Keith to board
Conformal Medical appoints George Fazio to board

What to read next

GENova Biotherapeutics names Aaron Whiteman as chief executive officer
Talecris Biotherapeutics Holdings: John Perkins EVP, global commercial operations
Aeglea BioTherapeutics adds Anthony Quinn to board of directors